PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Biomerica, Inc. (BMRA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US09061H3075

CUSIP

09061H307

Sector

Healthcare

IPO Date

Jan 3, 2005

Highlights

Market Cap

$5.46M

EPS (TTM)

-$0.37

Total Revenue (TTM)

$5.58M

Gross Profit (TTM)

$597.00K

EBITDA (TTM)

-$5.49M

Year Range

$0.24 - $1.35

Target Price

$13.00

Short %

3.60%

Short Ratio

2.28

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Biomerica, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%50.00%100.00%SeptemberOctoberNovemberDecember2025February
105.03%
9.82%
BMRA (Biomerica, Inc.)
Benchmark (^GSPC)

Returns By Period

Biomerica, Inc. had a return of 196.57% year-to-date (YTD) and -17.59% in the last 12 months. Over the past 10 years, Biomerica, Inc. had an annualized return of 0.86%, while the S&P 500 had an annualized return of 11.26%, indicating that Biomerica, Inc. did not perform as well as the benchmark.


BMRA

YTD

196.57%

1M

48.33%

6M

105.02%

1Y

-17.59%

5Y*

-20.31%

10Y*

0.86%

^GSPC (Benchmark)

YTD

4.01%

1M

1.13%

6M

9.82%

1Y

22.80%

5Y*

12.93%

10Y*

11.26%

*Annualized

Monthly Returns

The table below presents the monthly returns of BMRA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202568.24%196.57%
2024-25.60%31.18%-31.80%-28.37%-2.58%-24.25%-24.76%32.97%-25.55%13.55%4.70%-22.95%-75.99%
2023-10.45%-10.00%-30.74%-28.88%3.01%-0.73%-2.94%-3.03%-32.80%13.93%-5.10%34.41%-62.69%
20229.51%1.88%3.00%-12.08%-10.94%-17.43%-4.15%27.80%11.02%-16.28%5.78%-3.74%-13.88%
202136.55%-9.85%-10.93%-14.65%-21.67%9.86%-6.48%19.47%0.45%2.00%5.66%-19.79%-21.89%
20200.86%-8.05%154.96%5.03%-13.85%12.06%25.66%-20.31%-4.55%-21.21%27.29%-28.35%64.68%
201948.71%6.15%-7.21%-7.23%-2.60%15.56%35.77%-20.11%15.25%-4.31%-2.89%0.13%77.88%
201812.03%8.35%-11.01%-11.88%14.33%-4.42%-6.68%-0.77%-0.61%-22.35%1.08%-39.50%-54.55%
201720.43%-11.19%-10.98%19.63%-4.58%5.20%5.67%-4.64%4.91%-0.36%24.19%8.72%62.61%
2016-10.85%-4.00%0.54%42.34%1.27%-5.96%22.29%57.61%-10.00%-0.38%-18.85%9.00%78.29%
20154.49%-11.72%-0.13%7.33%5.68%7.53%-25.00%1.47%11.70%1.76%4.05%43.33%44.94%
201415.38%-18.89%5.26%18.43%-6.59%8.24%2.17%-3.19%-4.95%8.67%1.06%-6.32%14.10%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of BMRA is 47, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of BMRA is 4747
Overall Rank
The Sharpe Ratio Rank of BMRA is 4141
Sharpe Ratio Rank
The Sortino Ratio Rank of BMRA is 6060
Sortino Ratio Rank
The Omega Ratio Rank of BMRA is 5656
Omega Ratio Rank
The Calmar Ratio Rank of BMRA is 3636
Calmar Ratio Rank
The Martin Ratio Rank of BMRA is 4141
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Biomerica, Inc. (BMRA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for BMRA, currently valued at -0.11, compared to the broader market-2.000.002.00-0.111.74
The chart of Sortino ratio for BMRA, currently valued at 1.02, compared to the broader market-4.00-2.000.002.004.006.001.022.36
The chart of Omega ratio for BMRA, currently valued at 1.11, compared to the broader market0.501.001.502.001.111.32
The chart of Calmar ratio for BMRA, currently valued at -0.16, compared to the broader market0.002.004.006.00-0.162.62
The chart of Martin ratio for BMRA, currently valued at -0.26, compared to the broader market-10.000.0010.0020.0030.00-0.2610.69
BMRA
^GSPC

The current Biomerica, Inc. Sharpe ratio is -0.11. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Biomerica, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.11
1.74
BMRA (Biomerica, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Biomerica, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-94.44%
-0.43%
BMRA (Biomerica, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Biomerica, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Biomerica, Inc. was 98.34%, occurring on Dec 19, 2024. The portfolio has not yet recovered.

The current Biomerica, Inc. drawdown is 94.44%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.34%Mar 20, 20201197Dec 19, 2024
-80.56%Oct 4, 2007260Feb 2, 20091272May 26, 20161532
-67.92%Jan 11, 2018241Dec 31, 2018303Mar 18, 2020544
-49.33%Jun 14, 2005311Jan 12, 200739Apr 16, 2007350
-45.99%Aug 23, 201655Nov 8, 2016245Nov 3, 2017300

Volatility

Volatility Chart

The current Biomerica, Inc. volatility is 54.12%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%SeptemberOctoberNovemberDecember2025February
54.12%
3.01%
BMRA (Biomerica, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Biomerica, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Biomerica, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab